Atopic dermatitis is associated with active and passive cigarette smoking in adolescents

RECOMMENDED

Atopic Dermatitis

Loss-of-function mutations in CARD14 are associated with a severe variant of atopic dermatitis

doi: 10.1016/j.jaci.

Atopic Dermatitis

Is atopic dermatitis associated with obesity? A systematic review of observational studies

J Eur Acad Dermatol Venereol.

Ali Z, Suppli Ulrik C, Agner T, Thomsen SF

doi: 10.1111/jdv.14879.

Atopic Dermatitis

Genetic, Clinical, and Environmental Factors Associated With Persistent Atopic Dermatitis in Childhood

JAMA Dermatol.

Thorsteinsdottir S, Stokholm J, Thyssen JP, Nørgaard S, Thorsen J, Chawes BL, Bønnelykke K, Waage J, Bisgaard H

doi: 10.1001/jamadermatol.

Atopic Dermatitis

Association between atopic dermatitis and contact sensitization: A systematic review and meta-analysis

J Am Acad Dermatol.

Hamann CR, Hamann D, Egeberg A, Johansen JD, Silverberg J, Thyssen JP

doi: 10.1016/j.jaad.2017.02.001.

COMMENTED

Atopic Dermatitis

Association between parental autoimmune disease and atopic dermatitis in their offspring: a matched case-control study

doi: 10.1111/jdv.15413.

Atopic Dermatitis

Association of atopic dermatitis with depression, anxiety, and suicidal ideation in children and adults: A systematic review and meta-analysis

J Am Acad Dermatol.

Rønnstad ATM, Halling-Overgaard AS, Hamann CR, Skov L, Egeberg A, Thyssen JP

doi: 10.1016/j.jaad.2018.03.017.

Melanoma and Skin Cancer

Cigarette smoking and the risks of basal cell carcinoma and squamous cell carcinoma

J Invest Dermatol.

Dusingize JC, Olsen CM, Pandeya NP, Subramaniam P, Thompson BS, Neale RE, Green AC, Whiteman DC; QSkin Study

doi: 10.1016/j.jid.2017.03.027.

Atopic Dermatitis

Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial

Lancet

Reich K, Teixeira HD, de Bruin-Weller M, Bieber T, Soong W, Kabashima K, Werfel T, Zeng J, Huang X, Hu X, Hendrickson BA, Ladizinski B, Chu AD, Silverberg JI

doi: 10.1016/S0140-6736(21)00589-4

AcneAtopic Dermatitis

Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials

Lancet

Guttman-Yassky E, Teixeira HD, Simpson EL, Papp KA, Pangan AL, Blauvelt A, Thaçi D, Chu CY, Hong HC, Kato N, Paller AS, Calimlim B, Gu Y, Hu X, Liu M, Yang Y, Liu J, Tenorio AR, Chu AD, Irvine AD

doi: 10.1016/S0140-6736(21)00588-2

Related content

Loss-of-function mutations in CARD14 are associated with a severe variant of atopic dermatitis

Is atopic dermatitis associated with obesity? A systematic review of observational studies

Genetic, Clinical, and Environmental Factors Associated With Persistent Atopic Dermatitis in Childhood

Association between atopic dermatitis and contact sensitization: A systematic review and meta-analysis

Association between parental autoimmune disease and atopic dermatitis in their offspring: a matched case-control study

Association of atopic dermatitis with depression, anxiety, and suicidal ideation in children and adults: A systematic review and meta-analysis

Cigarette smoking and the risks of basal cell carcinoma and squamous cell carcinoma

Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial

Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials